Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 01)
Nitroglycerin Transdermal System
Product Images NDC 68382-311
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Nitroglycerin Transdermal System (NDC 68382-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 02)
This is a set of patient instructions for using a transdermal system containing 0.2 mg/hour of nitroglycerin. It includes information on proper storage, dosage, and application of the patch. The patch should be applied to the skin and left on for 12 to 14 hours, followed by a patch-free period, unless otherwise directed by a physician. The patch should be kept out of reach of children and should not be refrigerated. In case of side effects, patients may contact the FDA. The patch is distributed by Zydus Pharmaceuticals (USA) Inc.*
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 03)
The text provides instructions for using a nitroglycerin transdermal system, with tear-off guidelines for opening the package and applying the patch to the skin; however, it lacks the patient information leaflet. The patch is designed for the transdermal administration of nitroglycerin and is rated to release 0.4 mg/hr. The manufacturer and distributor information are provided along with storage instructions, warnings not to refrigerate the product, and to keep it out of the reach of children and pets.*
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 04)
This is a patient instruction leaflet for a transdermal patch containing nitroglycerin. The leaflet contains instructions on how to apply the patch, dosage recommendations and storage guidelines. It also advises patients to contact their doctor for any medical advice related to side effects and provides the necessary contact information for the FDA. The product is manufactured by Hercon Pharmaceuticals and distributed by Zydus Pharmaceuticals.*
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 100 2)
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 100 3)
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 2)
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 3)
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 4)
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 5)
Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 6)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
